Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Tandem Diabetes Care (TNDM US)
Watchlist
21
Analysis
Health Care
•
United States
Tandem Diabetes Care, Inc. produces medical devices. The Company designs, develops, and commercializes products for people with insulin-dependent diabetes. Tandem Diabetes Care offers its products to the medical industries in the United States.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Tandem Diabetes Care
•
21 Sep 2023 16:49
Tandem Diabetes Care (TNDM US): Q2 Sales Declined, Margin Deteriorated; 2023 Guidance Revised Lower
Tandem's Q2 sales declined 2% YoY to $195.9M, as global pump shipment plummeted 8% YoY to 29,494. The company has lowered 2023 sales guidance to...
Tina Banerjee
Follow
443 Views
Share
bearish
•
Tandem Diabetes Care
•
09 Jun 2023 17:48
Tandem Diabetes Care (TNDM US): Missed Earnings + Severe Competition = A Bitter Pill to Swallow
Tandem is consistently missing earnings expectations since 4Q21. The company’s nearest competitor has recently launched a new device in US, which...
Tina Banerjee
Follow
402 Views
Share
bullish
•
Eoflow
•
05 Dec 2023 16:02
EOFlow (Further) Tests Investor Patience
The Appellant Brief Is out. EOFlow flags. inter alia, the statute of limitations; whether Insulet faces a significant risk of irreparable harm;...
David Blennerhassett
Follow
1.4k Views
Share
bullish
•
Taisho Pharmaceutical Holdin
•
01 Dec 2023 08:51
(Mostly) Asia M&A, Nov 2023: Taisho Pharma, CIMC Vehicle, CMIC, Japan Best Rescue, Shidax
For the month of November, 16 new deals were discussed on Smartkarma with an overall deal size of ~US$13bn. The average premium for the new deals...
David Blennerhassett
Follow
470 Views
Share
bullish
•
JSR Corp
•
26 Nov 2023 07:05
Last Week in Event SPACE: JSR, Prosus/Tencent, Hollysys, Tata Consultancy, Geely, EOFlow
The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...
David Blennerhassett
Follow
412 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.30.3
x